Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 Patients

Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 Patients

Alena Novakova-Jiresova,1 Katerina Kopeckova,2 Ludmila Boublikova,1 Renata Chloupkova,3 Bohuslav Melichar,4 Lubos Petruzelka,5 Jindrich Finek,6 Ondrej Fiala,6,7 Peter Grell,8 Stanislav Batko,2 Zdenek Linke,2 Igor Kiss,8 Jana Prausova,2 Tomas Buchler1 1Department of Oncology, First Faculty of Medicin...

Full description

Bibliographic Details
Main Authors: Novakova-Jiresova A, Kopeckova K, Boublikova L, Chloupkova R, Melichar B, Petruzelka L, Finek J, Fiala O, Grell P, Batko S, Linke Z, Kiss I, Prausova J, Buchler T
Format: Article
Language:English
Published: Dove Medical Press 2020-07-01
Series:Cancer Management and Research
Subjects:
colorectal cancer
regorafenib
registry
survival
outcome analysis
Online Access:https://www.dovepress.com/regorafenib-for-metastatic-colorectal-cancer-an-analysis-of-a-registry-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/regorafenib-for-metastatic-colorectal-cancer-an-analysis-of-a-registry-peer-reviewed-article-CMAR

Similar Items